Oncology

Related Articles

Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09    Relevance Score: 68%

Hematopoiesis-related microRNA expression in myelodysplastic syndromes
Leukemia and Lymphoma, 11/06/09    Relevance Score: 67%

Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome
International Journal of Laboratory Hematology, 10/28/09    Relevance Score: 66%

Accelerated cellular senescence in myelodysplastic syndrome
Experimental Hematology, 10/22/09    Relevance Score: 66%

Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression
Blood, 10/09/09    Relevance Score: 66%

Today in Myeloproliferative Dz...keeping you current

Telomere shortening and chromosomal instability in myelodysplastic syndromes
Genes, Chromosomes and Cancer, 12/19/09

Living with multiple myeloma: experiences of patients and their informal caregivers
Supportive Care in Cancer, 12/17/09

Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis
Annals of Hematology, 12/17/09

Today in Pharmacology/Therapy...keeping you current

Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer
Medical Oncology, 12/17/09

Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4?,5-trimethoxylstilbene-3?-O-phosphate disodium (M410)
Investigational New Drugs, 12/17/09

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09